Discontinued — last reported Q4 '25
Johnson & Johnson SG&A increased by 0.6% to $5.92B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.1%, from $5.48B to $5.92B. Over 2 years (FY 2021 to FY 2024), SG&A shows relatively stable performance with a 1.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Increases may indicate aggressive marketing or expansion, while decreases often reflect cost-cutting measures or improved corporate efficiency.
The sum of all direct and indirect selling expenses and all general and administrative expenses of a company. This inclu...
Used to assess the 'leaness' of a company's corporate structure relative to its peers.
is_selling_general_and_administrative| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.43B | $6.07B | $6.00B | $6.51B | $5.94B | $6.23B | $6.09B | $6.14B | $5.40B | $5.26B | $5.68B | $5.48B | $6.45B | $5.11B | $5.89B | $5.92B |
| QoQ Change | — | +11.8% | -1.2% | +8.5% | -8.8% | +4.9% | -2.2% | +0.8% | -12.0% | -2.6% | +8.1% | -3.6% | +17.8% | -20.8% | +15.2% | +0.6% |
| YoY Change | — | — | — | — | +9.3% | +2.5% | +1.5% | +3.4% | -13.3% | — | -7.4% | +1.4% | — | -2.8% | +3.7% | +8.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.